These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 12100080

  • 1. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A, Colak O, Alatas O, Efe B.
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [Abstract] [Full Text] [Related]

  • 2. Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy.
    Barsal G, Taneli F, Atay A, Hekimsoy Z, Erciyas F.
    Tohoku J Exp Med; 2004 Jul; 203(3):183-8. PubMed ID: 15240927
    [Abstract] [Full Text] [Related]

  • 3. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [Abstract] [Full Text] [Related]

  • 4. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism.
    Simsek G, Karter Y, Aydin S, Uzun H.
    Chin J Physiol; 2003 Dec 31; 46(4):181-6. PubMed ID: 15074839
    [Abstract] [Full Text] [Related]

  • 5. Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism.
    Sabuncu T, Aksoy N, Arikan E, Ugur B, Tasan E, Hatemi H.
    Endocr Res; 2001 Dec 31; 27(1-2):203-13. PubMed ID: 11428712
    [Abstract] [Full Text] [Related]

  • 6. Bone turnover in hyperthyroidism before and after thyrostatic management.
    Isaia GC, Roggia C, Gola D, Stefano MD, Gallone G, Aimo G, Ardissone P, Mussetta M.
    J Endocrinol Invest; 2000 Dec 31; 23(11):727-31. PubMed ID: 11194705
    [Abstract] [Full Text] [Related]

  • 7. Serum cytokines in thyrotoxicosis.
    Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM.
    J Clin Endocrinol Metab; 1999 Feb 31; 84(2):435-9. PubMed ID: 10022397
    [Abstract] [Full Text] [Related]

  • 8. Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover.
    Al-Shoumer KA, Vasanthy BA, Al-Zaid MM.
    Endocr Pract; 2006 Feb 31; 12(2):121-30. PubMed ID: 16690458
    [Abstract] [Full Text] [Related]

  • 9. Sclerostin and bone metabolism markers in hyperthyroidism before treatment and interrelations between them.
    Sarıtekin İ, Açıkgöz Ş, Bayraktaroğlu T, Kuzu F, Can M, Güven B, Mungan G, Büyükuysal Ç, Sarıkaya S.
    Acta Biochim Pol; 2017 Feb 31; 64(4):597-602. PubMed ID: 29059259
    [Abstract] [Full Text] [Related]

  • 10. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.
    Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P.
    Thyroid; 1996 Jun 31; 6(3):169-75. PubMed ID: 8837322
    [Abstract] [Full Text] [Related]

  • 11. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy.
    Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P.
    Thyroid; 1996 Jun 31; 6(3):161-8. PubMed ID: 8837321
    [Abstract] [Full Text] [Related]

  • 12. Markers of bone turnover in hyperthyroidism and the effects of treatment.
    Garnero P, Vassy V, Bertholin A, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Apr 31; 78(4):955-9. PubMed ID: 8157727
    [Abstract] [Full Text] [Related]

  • 13. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan 31; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.
    Legovini P, De Menis E, Da Rin G, Roiter I, Breda F, Artuso V, Di Virgilio R, Conte N.
    Horm Metab Res; 1994 Jul 31; 26(7):334-7. PubMed ID: 7959610
    [Abstract] [Full Text] [Related]

  • 16. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H, Papapetrou PD.
    J Clin Endocrinol Metab; 2000 Mar 31; 85(3):1099-106. PubMed ID: 10720046
    [Abstract] [Full Text] [Related]

  • 17. [The influence of hyperthyroidism and glucocorticosteroid treatment on bone metabolism in patients with Graves' disease and ophthalmopathy].
    Kaźmierczyk-Puchalska A, Kulig G, Krzyzanowska-Swiniarska B, Pilarska K.
    Endokrynol Pol; 2005 Mar 31; 56(3):259-64. PubMed ID: 16350719
    [Abstract] [Full Text] [Related]

  • 18. Serum cytokines and bone metabolism in patients with thyroid dysfunction.
    Sekeroglu MR, Altun ZB, Algün E, Dülger H, Noyan T, Balaharoglu R, Oztürk M.
    Adv Ther; 2006 Mar 31; 23(3):475-80. PubMed ID: 16912030
    [Abstract] [Full Text] [Related]

  • 19. Biochemical bone markers in patients with multiple myeloma.
    Nawawi H, Samson D, Apperley J, Girgis S.
    Clin Chim Acta; 1996 Sep 30; 253(1-2):61-77. PubMed ID: 8879839
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.
    Celik I, Akalin S, Erbaş T.
    Eur J Endocrinol; 1995 Jun 30; 132(6):668-72. PubMed ID: 7788003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.